|
1
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long Noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pekarsky Y and Croce CM: Noncoding RNA
genes in cancer pathogenesis. Adv Biol Regul. 71:219–223. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shang Q, Yang Z, Jia R and Ge S: The novel
roles of circRNAs in human cancer. Mol Cancer. 18:62019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang
Y, Shi Y, Shen Y, Liu X, Lai W, et al: A G3BP1-interacting lncRNA
promotes ferroptosis and apoptosis in cancer via nuclear
sequestration of p53. Cancer Res. 78:3484–3496. 2018.PubMed/NCBI
|
|
7
|
Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S,
Zeng Z, He C, Liu ML, Huang K, Zhong JX, et al: Hypoxia-induced
LncRNA-BX111 promotes metastasis and progression of pancreatic
cancer through regulating ZEB1 transcription. Oncogene.
37:5811–5828. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu CY, Zhang YH, Li RB, Zhou LY, An T,
Zhang RC, Zhai M, Huang Y, Yan KW, Dong YH, et al: LncRNA CAIF
inhibits autophagy and attenuates myocardial infarction by blocking
p53-mediated myocardin transcription. Nat Commun. 9:292018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J,
Zhou Z, Zhang W, Qin L and Huang G: LncRNA PVT1 promotes
angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Oncogene. 37:4094–4109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang
Y, Jia L, Li S; Cancer Genome Atlas Research Network, ; Xie W and
Yang D: lncRNA epigenetic landscape analysis identifies EPIC1 as an
oncogenic lncRNA that Interacts with MYC and promotes cell-cycle
progression in cancer. Cancer Cell. 33:706–720.e9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qian H, Chen L, Huang J, Wang X, Ma S, Cui
F, Luo L, Ling L, Luo K and Zheng G: The lncRNA MIR4435-2HG
promotes lung cancer progression by activating β-catenin
signalling. J Mol Med (Berl). 96:753–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai IL, Yang CA, Lin PC, Chan WL, Lee YT,
Yen JC, Chang YS and Chang JG: Long noncoding RNA MIAT promotes
non-small cell lung cancer proliferation and metastasis through
MMP9 activation. Oncotarget. 8:98148–98162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su W, Feng S, Chen X, Yang X, Mao R, Guo
C, Wang Z, Thomas DG, Lin J, Reddy RM, et al: Silencing of long
noncoding RNA MIR22HG triggers cell Survival/Death signaling via
oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res.
78:3207–3219. 2018.PubMed/NCBI
|
|
17
|
Li S, Zhao H, Li J, Zhang A and Wang H:
Downregulation of long non-coding RNA LET predicts poor prognosis
and increases Notch signaling in non-small cell lung cancer.
Oncotarget. 9:1156–1168. 2017.PubMed/NCBI
|
|
18
|
Wu Y, Lyu H, Liu H, Shi X, Song Y and Liu
B: Downregulation of the long noncoding RNA GAS5-AS1 contributes to
tumor metastasis in non-small cell lung cancer. Sci Rep.
6:310932016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun GG, Lu YF, Cheng YJ and Hu WN: The
expression of BTG1 is downregulated in NSCLC and possibly
associated with tumor metastasis. Tumour Biol. 35:2949–2957. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HS, Kundu J, Kim RN and Shin YK:
Transducer of ERBB2.1 (TOB1) as a Tumor suppressor: A mechanistic
perspective. Int J Mol Sci. 16:29815–29828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho KJ, Do NL, Otu HH, Dib MJ, Ren X,
Enjyoji K, Robson SC, Terwilliger EF and Karp SJ: Tob1 is a
constitutively expressed repressor of liver regeneration. J Exp
Med. 207:1197–1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang YW, Nasto RE, Varghese R, Jablonski
SA, Serebriiskii IG, Surana R, Calvert VS, Bebu I, Murray J, Jin L,
et al: Acquisition of estrogen independence induces TOB1-related
mechanisms supporting breast cancer cell proliferation. Oncogene.
35:1643–1656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiao Y, Sun KK, Zhao L, Xu JY, Wang LL and
Fan SJ: Suppression of human lung cancer cell proliferation and
metastasis in vitro by the transducer of ErbB-2.1 (TOB1). Acta
Pharmacol Sin. 33:250–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu D, Zhou W, Wang S, Zhou Z, Wang S and
Chen L: Tob1 enhances radiosensitivity of breast cancer cells
involving the JNK and p38 pathways. Cell Biol Int. 39:1425–1430.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schulze-Topphoff U, Casazza S,
Varrin-Doyer M, Pekarek K, Sobel RA, Hauser SL, Oksenberg JR,
Zamvil SS and Baranzini SE: Tob1 plays a critical role in the
activation of encephalitogenic T cells in CNS autoimmunity. J Exp
Med. 210:1301–1309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun KK, Zhong N, Yang Y, Zhao L and Jiao
Y: Enhanced radiosensitivity of NSCLC cells by transducer of
erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway. Oncol
Rep. 29:2385–2391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao J, Li Z, Yang Z, Xue H, Chang H, Zhang
X, Li T and Guo K: Long noncoding RNA TOB1-AS1, an epigenetically
silenced gene, functioned as a novel tumor suppressor by sponging
miR-27b in cervical cancer. Am J Cancer Res. 8:1483–1498.
2018.PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yi C, Wan X, Zhang Y, Fu F, Zhao C, Qin R,
Wu H, Li Y and Huang Y: SNORA42 enhances prostate cancer cell
viability, migration and EMT and is correlated with prostate cancer
poor prognosis. Int J Biochem Cell Biol. 102:138–150. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mas-Ponte D, Carlevaro-Fita J, Palumbo E,
Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for
subcellular localisation of long noncoding RNAs. RNA. 23:1080–1087.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Imai H, Mori K, Wakuda K, Ono A, Akamatsu
H, Shukuya T, Taira T, Kenmotsu H, Naito T, Kaira K, et al:
Progression-free survival, post-progression survival, and tumor
response as surrogate markers for overall survival in patients with
extensive small cell lung cancer. Ann Thoracic Med. 10:61–66.
2015.
|
|
35
|
Zhou KR, Liu S, Cai L, Bin L, et al:
ENCORI: The encyclopedia of RNA interactomes.
|
|
36
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015.doi: 10.7554/eLife.05005. View Article : Google Scholar
|
|
37
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang C, Su C, Song Q, Dong F, Yu S and
Huo J: LncRNA PICART1 suppressed non-small cell lung cancer cells
proliferation and invasion by targeting AKT1 signaling pathway. Am
J Transl Res. 10:4193–4201. 2018.PubMed/NCBI
|
|
39
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
40
|
Shalem O, Sanjana NE and Zhang F:
High-throughput functional genomics using CRISPR-Cas9. Nat Revi
Genet. 16:299–311. 2015. View Article : Google Scholar
|
|
41
|
Chae DK, Ban E, Yoo YS, Kim EE, Baik JH
and Song EJ: MIR-27a regulates the TGF-β signaling pathway by
targeting SMAD2 and SMAD4 in lung cancer. Mol Carcinog.
56:1992–1998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang Y, Zang A, Jia Y, Shang Y, Zhang Z,
Ge K, Zhang J, Fan W and Wang B: Genistein inhibits A549 human lung
cancer cell proliferation via miR-27a and MET signaling. Oncol
Lett. 12:2189–2193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miao Y, Li J, Qiu X, Li Y, Wang Z and Luan
Y: miR-27a regulates the self renewal of the H446 small cell lung
cancer cell line in vitro. Oncol Rep. 29:161–168. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L
and Dong X: MiR-23a-mediated migration/invasion is rescued by its
target, IRS-1, in non-small cell lung cancer cells. J Cancer Res
Clin Oncol. 140:1661–1670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun Y, Xu T, Cao YW and Ding XQ: Antitumor
effect of miR-27b-3p on lung cancer cells via targeting Fzd7. Eur
Rev Med Pharmacol Sci. 21:4113–4123. 2017.PubMed/NCBI
|
|
46
|
Caramel J, Lacroix M, Le Cam L and Sardet
C: E4F1 connects the Bmi1-ARF-p53 pathway to epidermal stem
cell-dependent skin homeostasis. Cell Cycle. 10:866–867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang Liu and Liu G: lncRNA BANCR
suppresses cell viability and invasion and promotes apoptosis in
non-small-cell lung cancer cells in vitro and in vivo. Cancer Manag
Res. 11:3565–3574. 2019. View Article : Google Scholar : PubMed/NCBI
|
